No: Lmivudine is one of the earlier medications released for treating both HIV and hepatitis b but it is no longer considered adequate therapy for hepatitis b due to the risk of viral mutation leading to resistance to the medication within the first year or two of treatment. A much better choice would be tenofavir aka viread, (tenofovir) which has a much longer life-span comparatively.
Answered 6/10/2014
5.8k views
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question